Skip to main content
1454 search results for:

Daratumumab 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Daratumumab | News

    Daratumumab

    Transient neutropenia
  2. 01-05-2024 | Daratumumab | News

    Daratumumab/Dexamethasone/Pomalidomide

    Neutropenia
  3. 01-04-2024 | Erythropoietin | News

    Daratumumab/erythropoietin/rituximab

    Lack of efficacy
  4. 01-04-2024 | Daratumumab | News

    Daratumumab/Dexamethasone

    Non-responder
  5. 01-04-2024 | Daratumumab | News

    Daratumumab

    Infusion-related reaction
  6. 01-04-2024 | Daratumumab | News

    Daratumumab/Eculizumab/Steroids

    Lack of efficacy
  7. 01-04-2024 | Daratumumab | News

    Daratumumab

    Lack of efficacy
  8. 01-04-2024 | Daratumumab | News

    Daratumumab

    Treatment failure
  9. 19-04-2024 | Daratumumab | Online First

    Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma

    The introduction of daratumumab has improved treatment outcomes for multiple myeloma (MM). However, infectious complications are a concern in patients receiving daratumumab. Although some reports have explored the association between daratumumab

  10. 25-04-2024 | Daratumumab | Online First

    Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study

    The prognosis of patients diagnosed with relapsed or refractory (R/R) T-lymphoblastic leukemia/lymphoma (T-ALL/LBL) has consistently been unsatisfactory, with limited treatment options. As reports, the CAG regimen can serve as a salvage treatment …

  11. 01-03-2024 | Daratumumab | News

    Daratumumab

    Allergic reaction, cystitis and deep vein thrombosis
  12. 01-03-2024 | Daratumumab | News

    Daratumumab

    Lack of efficacy
  13. 01-03-2024 | Daratumumab | News

    Daratumumab/gemcitabine/oxaliplatin

    Lack of efficacy
  14. 01-03-2024 | Daratumumab | News

    Daratumumab

    Various toxicities
  15. 29-03-2024 | Daratumumab | Online First

    Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain

    While the introduction of immunomodulatory drugs, proteasome inhibitors and monoclonal antibodies over the last decade have led to a significant improvement in overall survival (OS) and progression-free survival (PFS) in multiple myeloma (MM) …

  16. 16-03-2024 | Elotuzumab | Online First

    Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study

    Elotuzumab-based regimens are sometimes selected for multiple myeloma treatment after daratumumab-based regimens. However, there has been insufficient discussion on the efficacy of elotuzumab after daratumumab. We used Kansai Myeloma Forum …

  17. 01-02-2024 | Daratumumab | News

    Daratumumab/dexamethasone/lenalidomide

    Lack of efficacy
  18. Open Access 22-03-2024 | Daratumumab | Online First

    Daratumumab therapy in a pediatric case of C3 nephritic factor-positive proliferative glomerulonephritis with monoclonal IgG deposits

    Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is an exceedingly rare cause of glomerulonephritis among children for which prognosis is generally poor, with low incidence of remission and high rates of recurrence …

  19. Open Access 01-12-2024 | Daratumumab | OriginalPaper

    Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma

    MM is the second most common haematological malignancy and accounts for approximately 1.8% of all new cancer cases worldwide [ 1 – 3 ]. Myeloma is usually symptomatic and reduces the patient's health-related quality of life (HRQoL) [ 4 ]. Most …

  20. 06-03-2024 | Daratumumab | Online First

    Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma

    Multiple myeloma (MM) is a clonal plasma cell malignancy that originates in bone marrow and produces excess monoclonal immunoglobulins that can cause complications such as bone pain, kidney dysfunction, and anemia [ 1 ]. With the use of novel …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.